Skip to main content

Advertisement

SpringerLink
Log in

Mediators of fibrosis and apoptosis in obstructive uropathies

  • Published:
Current Urology Reports Aims and scope Submit manuscript

Abstract

Upper urinary tract obstruction, regardless of its cause, often poses a significant clinical challenge to the urologist. Renal cellular and molecular events that occur in response to upper urinary tract obstruction result in a progressive and permanent loss in renal function when left untreated. These pathologic changes include the development of renal fibrosis, tubular atrophy, interstitial inflammation, and apoptotic renal cell death. Several cytokines and growth factors have been identified as major contributors to obstruction-induced renal fibrosis and apoptotic cell death, most notably transforming growth factor-β1 (TGF-β1), angiotensin, nuclear factor-κB (NF-κB), and tumor necrosis factor-α (TNF-α). This review examines the challenges of upper urinary tract obstruction and the role of these mediators in obstruction-induced renal injury.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Klahr S, Morrissey JJ: The role of growth factors, cytokines, and vasoactive compounds in obstructive nephropathy. Semin Nephrol 1998, 18:622–632.

    PubMed  CAS  Google Scholar 

  2. Gobe GC, Axelsen RA: Genesis of renal tubular atrophy in experimental hydronephrosis in the rat: role of apoptosis. Lab Invest 1987, 56:273–281.

    PubMed  CAS  Google Scholar 

  3. Morrissey JJ, Ishidoya S, McCracken R, et al.: The effect of ACE inhibitors on the expression of matrix genes and the role of p53 and p21 (WAF1) in experimental renal fibrosis. Kidney Int 1996, 54(suppl):S83.

    CAS  Google Scholar 

  4. Border WA, Noble NA: Transforming growth factor beta in tissue fibrosis. N Engl J Med 1994, 331:1286–1292.

    Article  PubMed  CAS  Google Scholar 

  5. Eddy AA: Molecular insights into renal interstitial fibrosis. J Am Soc Nephrol 1996, 7:2495–2508.

    PubMed  CAS  Google Scholar 

  6. Roberts AB, McCune BK, Sporn MB: TGF-beta: regulation of extracellular matrix. Kidney Int 1992, 41:557–559.

    Article  PubMed  CAS  Google Scholar 

  7. Miyajima A, Chen J, Lawrence C, et al.: Antibody to transforming growth factor-beta ameliorates tubular apoptosis in unilateral ureteral obstruction. Kidney Int 2000, 58:2301–2313.

    Article  PubMed  CAS  Google Scholar 

  8. Ishidoya S, Morrissey J, McCracken R, et al.: Delayed treatment with enalapril halts tubulointerstitial fibrosis in rats with obstructive nephropathy. Kidney Int 1996, 49:1110–1119.

    Article  PubMed  CAS  Google Scholar 

  9. Diamond JR, Ricardo SD, Klahr S: Mechanisms of interstitial fibrosis in obstructive nephropathy. Semin Nephrol 1998, 18:594–602.

    PubMed  CAS  Google Scholar 

  10. Schnaper HW, Hayashida T, Poncelet AC: It’s a Smad world: regulation of TGF-beta signaling in the kidney. J Am Soc Nephrol 2002, 13:1126–1128.

    PubMed  CAS  Google Scholar 

  11. Chung KH, Chevalier RL: Arrested development of the neonatal kidney following chronic ureteral obstruction. J Urol 1996, 155:1139–1144.

    Article  PubMed  CAS  Google Scholar 

  12. Kaneto H, Morrissey J, Klahr S: Increased expression of TGFbeta 1 mRNA in the obstructed kidney of rats with unilateral ureteral ligation. Kidney Int 1993, 44:313–321.

    Article  PubMed  CAS  Google Scholar 

  13. Diamond JR, Kees-Folts D, Ding G, et al.: Macrophages, monocyte chemoattractant peptide-1, and TGF-beta 1 in experimental hydronephrosis. Am J Physiol 1994, 266:F926-F933.

    PubMed  CAS  Google Scholar 

  14. Sutaria PM, Ohebshalom M, McCaffrey TA, et al.: Transforming growth factor-beta receptor types I and II are expressed in renal tubules and are increased after chronic unilateral ureteral obstruction. Life Sci 1998, 62:1965–1972.

    Article  PubMed  CAS  Google Scholar 

  15. Fukuda K, Yoshitomi K, Yanagida T, et al.: Quantification of TGF-beta1 mRNA along rat nephron in obstructive nephropathy. Am J Physiol Renal Physiol 2001, 281:F513-F521.

    PubMed  CAS  Google Scholar 

  16. Schreiner GF, Harris KP, Purkerson ML, et al.: Immunological aspects of acute ureteral obstruction: immune cell infiltrate in the kidney. Kidney Int 1988, 34:487–493.

    Article  PubMed  CAS  Google Scholar 

  17. Diamond JR, Levinson M, Kreisberg R, et al.: Increased expression of decorin in experimental hydronephrosis. Kidney Int 1997, 51:1133–1139.

    Article  PubMed  CAS  Google Scholar 

  18. Kuncio GS, Neilson EG, Haverty T: Mechanisms of tubulointerstitial fibrosis. Kidney Int 1991, 39:550–556.

    Article  PubMed  CAS  Google Scholar 

  19. Roberts AB, Sporn MB: Transforming growth factor beta. Adv Cancer Res 1988, 51:107–145.

    PubMed  CAS  Google Scholar 

  20. Postlethwaite AE, Keski-Oja J, Moses HL, et al.: Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor beta. J Exp Med 1987, 165:251–256.

    Article  PubMed  CAS  Google Scholar 

  21. Chandrasekhar S, Harvey AK: Transforming growth factor-beta is a potent inhibitor of IL-1 induced protease activity and cartilage proteoglycan degradation. Biochem Biophys Res Commun 1988, 157:1352–1359.

    Article  PubMed  CAS  Google Scholar 

  22. Vassalli JD, Sappino AP, Belin D: The plasminogen activator/ plasmin system. J Clin Invest 1991, 88:1067–1072.

    PubMed  CAS  Google Scholar 

  23. Malyankar UM, Almeida M, Johnson RJ, et al.: Osteopontin regulation in cultured rat renal epithelial cells. Kidney Int 1997, 51:1766–1773.

    Article  PubMed  CAS  Google Scholar 

  24. Ishidoya S, Morrissey J, McCracken R, et al.: Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral obstruction. Kidney Int 1995, 47:1285–1294.

    Article  PubMed  CAS  Google Scholar 

  25. El-Dahr SS, Gee J, Dipp S, et al.: Upregulation of renin-angiotensin system and downregulation of kallikrein in obstructive nephropathy. Am J Physiol 1993, 264:F874-F881.

    PubMed  CAS  Google Scholar 

  26. Pimentel JL Jr, Martinez-Maldonado M, Wilcox J, et al.: Regulation of renin-angiotensin system in unilateral ureteral obstruction. Kidney Int 1993, 44:390–400.

    Article  PubMed  CAS  Google Scholar 

  27. Pimentel JL Jr, Montero A, Wang S, et al.: Sequential changes in renal expression of renin-angiotensin system genes in acute unilateral ureteral obstruction. Kidney Int 1995, 48:1247–1253.

    Article  PubMed  CAS  Google Scholar 

  28. Ricardo SD, Levinson ME, DeJoseph MR, et al.: Expression of adhesion molecules in rat renal cortex during experimental hydronephrosis. Kidney Int 1996, 50:2002–2010.

    Article  PubMed  CAS  Google Scholar 

  29. Klahr S, Harris K, Purkerson ML: Effects of obstruction on renal functions. Pediatr Nephrol 1988, 2:34–42.

    Article  PubMed  CAS  Google Scholar 

  30. Klahr S: New insights into the consequences and mechanisms of renal impairment in obstructive nephropathy. Am J Kidney Dis 1991, 18:689–699.

    PubMed  CAS  Google Scholar 

  31. Bernstein KE, Berk BC: The biology of angiotensin II receptors. Am J Kidney Dis 1993, 22:745–754.

    PubMed  CAS  Google Scholar 

  32. Meister B, Lippoldt A, Bunnemann B, et al.: Cellular expression of angiotensin type-1 receptor mRNA in the kidney. Kidney Int 1993, 44:331–336.

    Article  PubMed  CAS  Google Scholar 

  33. Sechi LA, Grady EF, Griffin CA, et al.: Distribution of angiotensin II receptor subtypes in rat and human kidney. Am J Physiol 1992, 262:F236-F240.

    PubMed  CAS  Google Scholar 

  34. Yoo KH, Thornhill BA, Wolstenholme JT, et al.: Tissue-specific regulation of growth factors and clusterin by angiotensin II. Am J Hypertens 1998, 11:715–722.

    Article  PubMed  CAS  Google Scholar 

  35. Klahr S, Morrissey JJ: Comparative study of ACE inhibitors and angiotensin II receptor antagonists in interstitial scarring. Kidney Int Suppl 1997, 63:S111-S114.

    PubMed  CAS  Google Scholar 

  36. Guo G, Morrissey J, McCracken R, et al.: Contributions of angiotensin II and tumor necrosis factor-alpha to the development of renal fibrosis. Am J Physiol Renal Physiol 2001, 280:F777-F785.

    PubMed  CAS  Google Scholar 

  37. Morrissey JJ, Klahr S: Differential effects of ACE and AT1 receptor inhibition on chemoattractant and adhesion molecule synthesis. Am J Physiol 1998, 274:F580-F586.

    PubMed  CAS  Google Scholar 

  38. Chevalier RL, Thornhill BA, Wolstenholme JT: Renal cellular response to ureteral obstruction: role of maturation and angiotensin II. Am J Physiol 1999, 277:F41-F47. This article reviews the role of angiotensin II and its receptors in unilateral ureteral obstruction. It carefully examines the renal cellular response UUO in the neonatal and adult rat and the effect of receptor inhibition on renal cellular proliferation and apoptosis.

    PubMed  CAS  Google Scholar 

  39. Morrissey JJ, Klahr S: Effect of AT2 receptor blockade on the pathogenesis of renal fibrosis. Am J Physiol 1999, 276:F39-F45.

    PubMed  CAS  Google Scholar 

  40. Klahr S, Morrissey J: Angiotensin II and gene expression in the kidney. Am J Kidney Dis 1998, 31:171.

    PubMed  CAS  Google Scholar 

  41. Haralambous-Gasser A, Chan D, Walker RG, et al.: Collagen studies in newborn rat kidneys with incomplete ureteric obstruction. Kidney Int 1993, 44:593–605.

    Article  PubMed  CAS  Google Scholar 

  42. Pimentel JL Jr, Sundell CL, Wang S, et al.: Role of angiotensin II in the expression and regulation of transforming growth factorbeta in obstructive nephropathy. Kidney Int 1995, 48:1233–1246.

    Article  PubMed  CAS  Google Scholar 

  43. Kaneto H, Morrissey J, McCracken R, et al.: The expression of mRNA for tumor necrosis factor-alpha increases in the obstructed kidney of rats soon after unilateral ureteral ligation. Nephrology 1996, 2:161.

    Article  CAS  Google Scholar 

  44. Morrissey JJ, Klahr S: Rapid communication: enalapril decreases nuclear factor kappa B activation in the kidney with ureteral obstruction. Kidney Int 1997, 52:926–933.

    Article  PubMed  CAS  Google Scholar 

  45. Morrissey J, Klahr S: Transcription factor NF-kappaB regulation of renal fibrosis during ureteral obstruction. Semin Nephrol 1998, 18:603–611.

    PubMed  CAS  Google Scholar 

  46. Miyajima A, Kosaka T, Seta K, et al.: Novel nuclear factor kappa B activation inhibitor prevents inflammatory injury in unilateral ureteral obstruction. J Urol 2003, 169:1559–1563.

    Article  PubMed  CAS  Google Scholar 

  47. Li J, Brasier AR: Angiotensinogen gene activation by angiotensin II is mediated by the rel A (nuclear factor-kappaB p65) transcription factor: one mechanism for the renin angiotensin system positive feedback loop in hepatocytes. Mol Endocrinol 1996, 10:252–264.

    Article  PubMed  CAS  Google Scholar 

  48. Baeuerle PA, Henkel T: Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 1994, 12:141–179.

    PubMed  CAS  Google Scholar 

  49. Hirahashi J, Takayanagi A, Hishikawa K, et al.: Overexpression of truncated I kappa B alpha potentiates TNF-alpha-induced apoptosis in mesangial cells. Kidney Int 2000, 57:959–968.

    Article  PubMed  CAS  Google Scholar 

  50. Sumitomo M, Tachibana M, Nakashima J, et al.: An essential role for nuclear factor kappa B in preventing TNF-alphainduced cell death in prostate cancer cells. J Urol 1999, 161:674–679.

    Article  PubMed  CAS  Google Scholar 

  51. Lang A, Schoonhoven R, Tuvia S, et al.: Nuclear factor kappaB in proliferation, activation, and apoptosis in rat hepatic stellate cells. J Hepatol 2000, 33:49–58.

    Article  PubMed  CAS  Google Scholar 

  52. Cross JV, Deak JC, Rich EA, et al.: Quinone reductase inhibitors block SAPK/JNK and NFkappaB pathways and potentiate apoptosis. J Biol Chem 1999, 274:31150–31154.

    Article  PubMed  CAS  Google Scholar 

  53. Beg AA, Baltimore D: An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science 1996, 274:782–784.

    Article  PubMed  CAS  Google Scholar 

  54. Sugiyama H, Savill JS, Kitamura M, et al.: Selective sensitization to tumor necrosis factor-alpha-induced apoptosis by blockade of NF-kappaB in primary glomerular mesangial cells. J Biol Chem 1999, 274:19532–19537.

    Article  PubMed  CAS  Google Scholar 

  55. Van Antwerp DJ, Martin SJ, Kafri T, et al.: Suppression of TNFalpha-induced apoptosis by NF-kappaB. Science 1996, 274:787–789.

    Article  PubMed  Google Scholar 

  56. Donnahoo KK, Shames BD, Harken AH, et al.: The role of tumor necrosis factor in renal ischemia-reperfusion injury. J Urol 1999, 162:196–203.

    Article  PubMed  CAS  Google Scholar 

  57. Ortiz A, Bustos C, Alonso J, et al.: Involvement of tumor necrosis factor-alpha in the pathogenesis of experimental and human glomerulonephritis. Adv Nephrol Necker Hosp 1995, 24:53–77.

    PubMed  CAS  Google Scholar 

  58. Guo G, Morrissey J, McCracken R, et al.: Role of TNFR1 and TNFR2 receptors in tubulointerstitial fibrosis of obstructive nephropathy. Am J Physiol 1999, 277:F766-F772.

    PubMed  CAS  Google Scholar 

  59. Donnahoo KK, Meng X, Ayala A, et al.: Early kidney TNF-alpha expression mediates neutrophil infiltration and injury after renal ischemia-reperfusion. Am J Physiol 1999, 277:R922-R929.

    PubMed  CAS  Google Scholar 

  60. Donnahoo KK, Meldrum DR, Shenkar R, et al.: Early renal ischemia, with or without reperfusion, activates NFkappaB and increases TNF-alpha bioactivity in the kidney. J Urol 2000, 163:1328–1332.

    Article  PubMed  CAS  Google Scholar 

  61. Meldrum KK, Meldrum DR, Hile KL, et al.: p38 MAPK mediates renal tubular cell TNF-alpha production and TNF-alphadependent apoptosis during simulated ischemia. Am J Physiol Cell Physiol 2001, 281:C563-C570.

    PubMed  CAS  Google Scholar 

  62. Donnahoo KK, Meng X, Ao L, et al.: Differential cellular immunolocalization of renal tumour necrosis factor-alpha production during ischaemia versus endotoxaemia. Immunology 2001, 102:53–58.

    Article  PubMed  CAS  Google Scholar 

  63. Ranganath RM, Nagashree NR: Role of programmed cell death in development. Int Rev Cytol 2001, 202:159–242.

    PubMed  CAS  Google Scholar 

  64. Bellamy CO, Malcomson RD, Harrison DJ, et al.: Cell death in health and disease: the biology and regulation of apoptosis. Semin Cancer Biol 1995, 6:3–16.

    Article  PubMed  CAS  Google Scholar 

  65. Wyllie AH, Kerr JF, Currie AR: Cell death: the significance of apoptosis. Int Rev Cytol 1980, 68:251–306.

    Article  PubMed  CAS  Google Scholar 

  66. Miyajima A, Asano T, Yoshimura I, et al.: Tranilast ameliorates renal tubular damage in unilateral ureteral obstruction. J Urol 2001, 165:1714–1718.

    Article  PubMed  CAS  Google Scholar 

  67. Gerth JH, Kriegsmann J, Trinh TT, et al.: Induction of p27KIP1 after unilateral ureteral obstruction is independent of angiotensin II. Kidney Int 2002, 61:68–79.

    Article  PubMed  CAS  Google Scholar 

  68. Truong LD, Sheikh-Hamad D, Chakraborthy S, et al.: Cell apoptosis and proliferation in obstructive uropathy. Semin Nephrol 1998, 18:641–651. This article reviews apoptosis and cell proliferation, highlighting the functions of important molecules such as angiotensin II and TGF<a.

    PubMed  CAS  Google Scholar 

  69. Karin M, Cao Y, Greten FR, et al.: NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2002, 2:301–310.

    Article  PubMed  CAS  Google Scholar 

  70. Meldrum KK, Burnett AL, Meng X, et al.: Liposomal delivery of heat shock protein 72 into renal tubular cells blocks nuclear factor-kappaB activation, tumor necrosis factor-alpha production, and subsequent ischemia-induced apoptosis. Circ Res 2003, 92:293–299.

    Article  PubMed  CAS  Google Scholar 

  71. Ishibashi N, Weisbrot-Lefkowitz M, Reuhl K, et al.: Modulation of chemokine expression during ischemia/reperfusion in transgenic mice overproducing human glutathione peroxidases. J Immunol 1999, 163:5666–5677.

    PubMed  CAS  Google Scholar 

  72. Thevenod F, Friedmann JM, Katsen AD, et al.: Up-regulation of multidrug resistance P-glycoprotein via nuclear factor-kappaB activation protects kidney proximal tubule cells from cadmium- and reactive oxygen species-induced apoptosis. J Biol Chem 2000, 275:1887–1896.

    Article  PubMed  CAS  Google Scholar 

  73. Hsu H, Xiong J, Goeddel DV: The TNF receptor 1-associated protein TRADD signals cell death and NFkB activation. Cell 1995, 81:495–504.

    Article  PubMed  CAS  Google Scholar 

  74. Chinnaiyan AM, O’Rourke K, Tewari M, et al.: FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 1995, 81:505–512.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Children’s Hospital of New York Presbyterian Hospital, Weill Cornell Medical College, 525 East 68th Street, Box 94, 10021, New York, NY, USA

    Rosalia Misseri MD

  2. Riley Hospital for Children, Indiana University, Department of Pediatric Urology, Indianapolis, IN, USA

    Kirstan K. Meldrum MD

Authors
  1. Rosalia Misseri MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kirstan K. Meldrum MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Misseri, R., Meldrum, K.K. Mediators of fibrosis and apoptosis in obstructive uropathies. Curr Urol Rep 6, 140–145 (2005). https://doi.org/10.1007/s11934-005-0083-5

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11934-005-0083-5

Keywords

Search

Navigation